Shogo Kobayashi

10.7k citations
394 papers · 7.9k indexed · 1 hit paper · h-index 47
Topics
Pancreatic and Hepatic Oncology Research (113 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (81 papers)Hepatocellular Carcinoma Treatment and Prognosis (61 papers)
Partner nations
JapanUnited StatesChina

In The Last Decade

Shogo Kobayashi

363 papers receiving 7.7k citations

Hit Papers

mir-29 regulates Mcl-1 protein expression and apoptosis20072026201320192007200400600

Peers

Shogo Kobayashi
Comparison fields: 5 of 139
  • Molecular Biology 3.1k
  • Surgery 2.7k
  • Oncology 2.6k
  • Cancer Research 2.4k
  • Pulmonary and Respiratory Medicine 1.4k
Replace Kwok Wah Chan with:
Kwok Wah Chan Hong Kong
Mary P. Bronner United States
Toshiyoshi Fujiwara Japan
Thomas Longerich Germany
Matthias Evert Germany
Hidetoshi Eguchi Japan
Hiroaki Nagano Japan
Wolff Schmiegel Germany
Akimasa Nakao Japan
Georg Oberhuber Austria
Shogo Kobayashi relative to Kwok Wah Chan Hong Kong Kwok Wah Chan's profile →
Citations per field
00.5×1.5×2.5×
Kwok Wah Chan · 1×
Citations per year

Countries citing papers authored by Shogo Kobayashi

Since Specialization
Citations

This map shows the geographic impact of Shogo Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shogo Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shogo Kobayashi more than expected).

Fields of papers citing papers by Shogo Kobayashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shogo Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shogo Kobayashi. The network helps show where Shogo Kobayashi may publish in the future.

Co-authorship network of co-authors of Shogo Kobayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Shogo Kobayashi. A scholar is included among the top collaborators of Shogo Kobayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shogo Kobayashi. Shogo Kobayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 1
5 0
6 0
7 1
8 4
9 0
10 2
11 4
12 3
13 1
14 1
15 10
16 7
17 50
18 21
19 27
20
Beneficial effects of sodium salt of 17(R)-methyl-20-isopropylidenecarbacyclin on experimentally-induced ischemic hind limb lesions and blood viscosity.
5

About Shogo Kobayashi

Shogo Kobayashi is a scholar working on Hepatology, Transplantation and Oncology, having authored 394 papers that have together received 7.9k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (113 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (81 papers) and Hepatocellular Carcinoma Treatment and Prognosis (61 papers). The work is most often cited by research in Cancer Research (2.4k citations), Hepatology (1.2k citations) and Oncology (2.6k citations). Shogo Kobayashi has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Yuichiro� Doki, Gregory J. Gores, Hidetoshi Eguchi, Hiroaki Nagano, Masaki Mori, Steven F. Bronk, Shigeru Marubashi, Hiroshi Wada, Justin L. Mott and Masahiro Tanemura. Their work appears in journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026